Europe's New Fintech Unicorn, Revolut, Heads to America
*By Conor White*
Europe has a new unicorn.
The London-based fintech company Revolut announced last month it raised $250 million in Series C funding, bumping its valuation to $1.7 billion.
Revolut will use some of that money to jump across the pond to the United States.
"Given how aggravated people are with banking in general, we believe there's a huge market to go into the U.S. and cause serious disruption," said the Revolut chief marketing officer, Chad West. "So a huge amount of this capital will be expanding ourselves into the U.S., and building a real, innovative team out there."
In just 36 months, Revolut has raised $340 million, signed up more than 2 million customers in Europe, and has its sites set on conquering America and challenging companies like Robinhood.
"Right now Robinhood is purely on that road of wealth management and investments," West said Friday in an interview with Cheddar. "When Revolut comes to the U.S.A, there's nothing quite like us. We are the definition of a challenger bank."
For the full interview, [click here](https://cheddar.com/videos/london-based-fintech-revolut-plots-route-to-u-s).
SpoonTEK is an eating utensil that uses new technology to enhance flavors. Co-founders Ken and Cameron Davidov join Cheddar News to explain how the high-tech silverware can not only boost taste but also the health of its user.
Judith Donath, Fellow at Harvard's Berkman Center, and the founder of the Sociable Media Group at the MIT Media Lab, joins Cheddar Reveals to take a trip back through the origins of the Internet and how it's shaped human behavior over decades.
Mike Liebhold, Distinguished Fellow and Senior Technology Researcher, Institute for the Future, joins Cheddar Reveals to discuss what the future of the internet holds and why cell phones could give way to glasses and headsets as the most common way to access the Internet.
Catching you up on what you need to know on April 26, 2022, with Elon Musk’s purchase of Twitter for $44 billion, Russia warning of a possible threat of World War III, the FDA approving a COVID treatment for children under 12, and more.
